Zurcher Kantonalbank (Zurich Cantonalbank) Spectrum Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$1.27 - $2.42 $21,685 - $41,321	-17,075 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$2.89 - $4.45 $23,481 - $36,156	-8,125 Reduced 32.24%	17,075 $64,000
Q4 2020 Jan 28, 2021	BUY	$3.38 - $5.14 $31,853 - $48,439	9,424 Added 59.74%	25,200 $86,000
Q2 2020 Jul 28, 2020	BUY	$2.11 - $3.38 $21,984 - $35,216	10,419 Added 194.49%	15,776 $53,000
Q1 2019 Apr 29, 2019	SELL	$9.08 - $11.84 $14,482 - $18,884	-1,595 Reduced 22.94%	5,357 $57,000
Q3 2018 Nov 09, 2018	BUY	$16.52 - $24.82 $14,355 - $21,568	869 Added 14.29%	6,952 $117,000
Q1 2018 May 03, 2018	BUY	$16.09 - $23.07 $39,951 - $57,282	2,483 Added 68.97%	6,083 $98,000
Q4 2017 Jan 31, 2018	BUY	$13.36 - $20.73 $14,642 - $22,720	1,096 Added 43.77%	3,600 $68,000
Q3 2017 Nov 08, 2017	BUY	$8.75 - $14.07 $21,910 - $35,231	2,504	2,504 $35,000

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account